50대/남자
Anxiety?로 내원하였습니다.
기저질환으로 cabergoline을 복용 중이어서 '이 약제 때문인가?' 하는 생각을 해 보았습니다.
확률 문제이기는 하지만 아무래도 아닌 것 같습니다.
Adverse Reactions
>10%:
Central nervous system: Headache (26%), dizziness (15% to 17%)
Gastrointestinal: Nausea (27% to 29%)
1% to 10%:
Cardiovascular: Orthostatic hypotension (4%), hypotension (1%), palpitations (1%), peripheral edema (1%), syncope (1%)
Central nervous system: Fatigue (5% to 7%), drowsiness (2% to 5%), vertigo (1% to 4%), depression (3%), pain (2%), nervousness (1% to 2%), paresthesia (1% to 2%), anxiety (1%), insomnia (1%), lack of concentration (1%), malaise (1%)
Dermatologic: Acne vulgaris (1%), pruritus (1%)
Endocrine & metabolic: Hot flash (1% to 3%), dependent edema (1%)
Gastrointestinal: Constipation (7% to 10%), abdominal pain (5%), dyspepsia (2% to 5%), vomiting (2% to 4%), diarrhea (2%), flatulence (2%), xerostomia (2%), anorexia (1%), toothache (1%)
Genitourinary: Mastalgia (1% to 2%), dysmenorrhea (1%)
Neuromuscular & skeletal: Weakness (6% to 9%), arthralgia (1%)
Ophthalmic: Periorbital edema (1%), visual disturbance (1%)
Respiratory: Flu-like symptoms (1%), rhinitis (1%), throat irritation (1%)
<1%, postmarketing, and/or case reports: Aggressive behavior, alopecia, cardiac failure (in Parkinson's disease [PD] patients), confusion (in PD patients), constrictive pericarditis (in PD patients), duodenal ulcer (in PD patients), dyskinesia (in PD patients), epistaxis, facial edema, gastric ulcer (in PD patients), hallucination (in PD patients), heart valve disease, increased libido (including hypersexuality), pathological gambling, pleural effusion (in PD patients), psychosis, pulmonary fibrosis (in PD patients), weight gain, weight loss
